Skip to content

Clinical trials

Phase 3 Premature Birth trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Premature Birth Phase: Phase 3 Country / region: Italy Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20083
20091
20101
20111
20153
20167
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Withdrawn5
Terminated3
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Federico II University6
GlaxoSmithKline3
AMAG Pharmaceuticals, Inc.1
Elgan Pharma Ltd.1
Institut National de la Santé Et de la Recherche Médicale, France1
Juniper Pharmaceuticals, Inc.1
King's College Hospital NHS Trust1
University of Modena and Reggio Emilia1
University of Padova1
Università degli Studi di Brescia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Premature Birth17
Bronchopulmonary Dysplasia1
Hypothermia1
Malabsorption Syndromes1
Obstetric Labor, Premature1
Oligohydramnios1
Premature Rupture of Fetal Membranes1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.